Exagen (XGN) 주가, 시세, 뉴스 및 이력 | Benzinga

Exagen Inc (XGN) 주가, 시세, 뉴스 및 이력

XGNNASDAQ

Trade with Public

Trade with Public

$8.42

-0.06-0.71%

마지막 업데이트: Oct 14, 4:00 PM

개요뉴스 실적 전망 이벤트 목표가 재무 심리 지분 현황 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

주요 통계

개장가

$8.35

종가

$8.42

거래량 / 평균

611.50K / 331.82K

일 범위

$8.44 - $8.44

52주 범위

2.59 - 12.23

시가 총액

$199.32M

P/E 비율

-

배당 수익률

-

거래소

NASDAQ

RSI

-

매도 수량

3.22%

커버링 기간

2.46

Exagen Inc.의 최근 뉴스

Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Time to Play 5 Top-Ranked Stocks With Rising P/E?

Wall Street has been hovering around a record high level, which can trigger overvaluation concerns in some investors' minds. This is because investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio.

Zacks

Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday

With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Lisa Levin

Partner Content

Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments

Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available to more patients, as it announced the expansion of its exclusive worldwide rights for the development and c

FTC Solar, Exagen And 2 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones closed lower by over 300 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

재무

분기별

연간

종목명

매출 변동
총 변동
EBITDA 변동
EBIT 변동
실적 변동

현금흐름

영업 현금흐름 (TTM)

-6.50M

투자 현금흐름 (TTM)

-1.08M

재무 현금흐름 (TTM)

2.13M

유보 현금흐름 (TTM)

-7.59M

자본 지출 (TTM)

-1.09M

현금 순 변화 (TTM)

-5.45M

분석가 추세

1

4월

1

5월

1

6월

3

8월

1

10월

매수

보유

매도

강력 매도

분석가 평가

4.1

매수

강력 매수

매수

보유

매도

강력 매도

밸류에이션 지표

기업 가치

$206.88M

P/E 비율 (TTM)

-

P/E 비율 (FWD)

-

PEG 비율 (TTM)

-

P/S 비율 (TTM)

2.82

P/B 비율 (TTM)

16.82

수익 수율 % (TTM)

-9.67%

수익 수율 % (FWD)

-6.49%

EV / EBITDA (TTM)

-

가격 / EBITDA (TTM)

-

주가/잉여현금흐름 (TTM)

-

장부가 / 주식

$0.50

기업 부채

총 부채

$22.84M

장기 부채

$22.32M

장기 부채 발행 (TTM)

$0

장기 부채 상환 (TTM)

-$1.41M

현금 총액

$24.59M

부채비율

2.13

부채 발행 (TTM)

-$1.41M

부채 상환 (TTM)

-$1.41M